Post hoc pooled analysis of first-line (1L) pembrolizumab (pembro) for advanced urothelial carcinoma (UC): Outcomes by response at week nine in KEYNOTE-052 and KEYNOTE-361.

Powles T., Alva A. S., Ozguroglu M., O'Donnell P. H., Loriot Y., Csoszi T., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.40, sa.6, 2022 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 40 Sayı: 6
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1200/jco.2022.40.6_suppl.519
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • İstanbul Üniversitesi Adresli: Evet